[Tubal obstruction with an implant inserted by hysteroscopy: a report of 50 cases].

BACKGROUND: The Essure contraceptive device consists of a titanium and nickel coiled spring containing Dacron fibers. It is placed under hysteroscopic visualizaron in the proximal section of the Fallopian tube. The microinsert acts by inducing a tissue reaction that permanently blocks the tube within three months. OBJECTIVE: Show our experience in the use and insertion of the Essure device in a private office. METHODS: We reviewed insertion procedure complications degree of tolerance and acceptance by user. Between June 2008 and May 2013 fifty cases with Essure placement were made in our office. RESULTS: The average age was 36 years as for the average number of pregnancies was two. The procedure time average was 6 minutes 25 seconds no intraoperative complication was reported. All patients expressed very good tolerance and high degree of satisfaction with the procedure. A simple abdominal radiography was performed three months after the hysteroscopy to dem6nstrate the correct placement and position of the device in all patients. CONCLUSSION: The number of patients is enough to show the advantages of the method and the possibility of performing it in an ambulatory environment as it can be a private office with the correct equipment to do it.